In this context, we have recently identified a subset of Programmed Death-Ligand 1 (PD-L1)-expressing NK cells, that arise in tumor bearing mice which can inhibit tumor-specific CD8+ T cell priming (30). This evidence concerns the gene CD274 and neoplasm.